Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
Bridget E Collins,1 Jeffrey L Neul2 1Medical Scientist Training Program, Vanderbilt University, Nashville, TN, USA; 2Vanderbilt Kennedy Center, Departments of Pediatrics, Pharmacology, and Special Education, Vanderbilt University Medical Center and Vanderbilt University, Nashville, TN, USACorrespond...
Main Authors: | Collins BE, Neul JL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/rett-syndrome-and-mecp2-duplication-syndrome-disorders-of-mecp2-dosage-peer-reviewed-fulltext-article-NDT |
Similar Items
-
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
by: Katrina V. Good, et al.
Published: (2021-01-01) -
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
by: Shervin Pejhan, et al.
Published: (2021-01-01) -
MeCP2 and transcriptional control of eukaryotic gene expression
by: Ghanan Bin Akhtar, et al.
Published: (2022-06-01) -
MeCP2 and Chromatin Compartmentalization
by: Annika Schmidt, et al.
Published: (2020-04-01) -
Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials
by: Adele Gaspar Lopes, et al.
Published: (2024-01-01)